SecBot SecBot
8-K ·Filed May 21, 2026

FONR

FONAR CORP
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001193125-26-234914
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor the outcome of the May 28 special meeting. If the merger is approved, shares will be cashed out at the merger price (not disclosed in this filing); if it fails, the stock could revert to pre-announcement levels.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
FONR ▲ +1.14% at T+5d
NEUTRAL call +1.14% · α vs SPY -0.52% · entry $18.90 → $19.11
Next anchor: T+20d due 4mo ago
Entry = T+0 close
May 21, 2026
via day close
T+1d
+0.08%
call +0.08% · α -0.51%
$18.91
settled 5mo ago
T+5d
+1.14%
call +1.14% · α -0.52%
$19.11
settled 5mo ago
T+20d
Pending
due 4mo ago
T+60d
Pending
due 2mo ago

Price Chart

Loading chart...

Executive Summary

FONAR filed supplemental disclosures to its definitive proxy statement in connection with a pending going-private merger with an entity controlled by its CEO. The supplements address stockholder litigation alleging inadequate disclosures and include corrected background details and fairness opinion figures. The special stockholder vote is scheduled for May 28, 2026.

Key Facts

  • Special stockholder meeting to vote on going-private merger is May 28, 2026.
  • Supplemental disclosures added in response to demand letters and draft complaints from purported stockholders.
  • Marshall & Stevens estimated liquidation value of $14.63 per share in a fairness analysis.
  • Company states no post-signing negotiations regarding officer/director employment arrangements.
  • Transaction is a management buyout led by CEO/Chairman Timothy Damadian.

Financial Impact

No new financial figures; existing merger consideration unchanged by this filing.

Risk Factors

  • Stockholder litigation could delay or block the merger despite the supplemental disclosures.
  • Management buyout may face opposition from minority shareholders, creating uncertainty around deal completion.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-234914
Document: 0001193125-26-234914-index-headers.html0001193125-26-234914
Document: 0001193125-26-234914-index.html0001193125-26-234914
Document: 0001193125-26-234914.txt0001193125-26-234914
6 reports for FONR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FONR — sortable, filterable
TypeNow
Jun 15, 2026
19w ago
15-12G
BEARISH ★ 7/10
—awaiting T+5——
Jun 3, 2026
20w ago
8-K
NEUTRAL ★ 7/10
$19.09awaiting T+5——
May 21, 2026
22w ago
DEFA14A
NEUTRAL ★ 3/10
$18.90 $19.11▲ +1.14%▼ −0.52%—
May 21, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$18.90 $19.11▲ +1.14%▼ −0.52%—
May 12, 2026
23w ago
DEFA14A
BEARISH ★ 7/10
$18.86 $18.86· 0.00%▼ −1.16%—
May 12, 2026
23w ago
8-K
BEARISH ★ 6/10
$18.86 $18.86· 0.00%▼ −1.16%—
Showing 6 of 6

US Market Status

Market Open — Closes in 1h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 21, 2026